Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Fred Hutchinson Cancer Research Center has a 50% FTE Statistical Research Associate (SRA) I position available through the Cancer Prevention Department. Specifically, this SRA I position is under the direction of Dr. Polly Newcomb within the Division of Public Health Sciences at Fred Hutch. Dr. Newcomb is a leading epidemiologist in the fields of cancer genetics, etiology, screening, and survival. Her research program investigates the causes, treatments, and outcomes of colon cancer using large, population-based studies, clinical trials, and collaboration with local medical centers. Most recently, she has focused on germline and genetics of colorectal neoplasms in sporadic and familial disease in relation to risk and clinical outcomes. We are flexible on the FTE, if the applicant is willing to take on additional (administrative) tasks.
This is a part-time (approximately 20 hours per week) role. The SRA I’s duties will allow participation along the entire research continuum, from proposal submission to dissemination of results.